Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  PDF of this article
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box Social Bookmarking
 Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter
What's this?
box PubMed
Articles in PubMed by Author:
 arrow  Vijan, S.
space
 arrow  Hayward, R. A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Estimated Benefits of Glycemic Control in Microvascular Complications in Type 2 Diabetes

right arrow Sandeep Vijan, MD, MS; Timothy P. Hofer, MD, MS; and Rodney A. Hayward, MD

1 November 1997 | Volume 127 Issue 9 | Pages 788-795

Background: The benefits of intensive glycemic control in patients with type 2 diabetes are not well quantified. It is therefore not clear which patients will benefit most from aggressive glycemic control.

Objective: To evaluate the efficacy of glycemic control in type 2 diabetes.

Design: Markov decision model.

Patients: Diabetic patients at a health maintenance organization.

Main Outcome Measures: Risks for developing blindness and end-stage renal disease; number of patients and patient-years needed to treat to prevent complications.

Results: For a patient in whom diabetes developed before 50 years of age, reducing hemoglobin A1c levels from 9% to 7% results in an estimated 2.3-percentage point decrease (from 2.6% to 0.3%) in lifetime risk for blindness due to retinopathy. The same change in a patient with diabetes onset at 65 years of age would be expected to decrease the risk for blindness by 0.5 percentage points (from 0.5% to <0.1%). However, the Markov model predicts substantially greater benefit when moving from poor to moderate glycemic control than when moving from moderate to almost-normal glycemic control. Targeting less than 20% of the patients at one health maintenance organization for intensified therapy may prevent more than 80% of the preventable patient-time spent blind. The risks for end-stage renal disease and the risk reduction provided by improved glycemic control are lower than those for blindness.

Conclusions: This probability model, based on extrapolation from the experience with type 1 diabetes, suggests that patients with early onset of type 2 diabetes will accrue substantial benefit from almost-normal glycemic control. In patients with later onset, moderate glycemic control prevents most end-stage complications caused by microvascular disease. These results have important implications for informing patients and allocating health care resources.

Author and Article Information
space

From the Veterans Affairs Center for Practice Management and Outcomes Research and the University of Michigan School of Medicine, Ann Arbor, Michigan.
Grant Support: In part by grant HSO 6665-01 from the Agency for Health Care Policy and Research. Dr. Vijan is an Agency for Health Care Policy and Research Health Services Research Fellow, and Dr. Hofer is a Veterans Affairs Health Services Research and Development Career Development Awardee.
Requests for Reprints: Sandeep Vijan, MD, Veterans Affairs Health Services Research and Development, PO Box 130170, Ann Arbor, MI 48113-0170.
Current Author Addresses: Drs. Vijan, Hofer, and Hayward: Veterans Affairs Health Services Research and Development, PO Box 130170, Ann Arbor, MI 48113-0170.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in Annals:

Editorials
Glucose Control in Type 2 Diabetes Mellitus
Jay S. Skyler
Annals 1997 127: 837-839. [Full Text]  



This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
J. W. M. Cheng, S. H. Bhatt, and J. D. Goldman-Levine
The Benefit and Risk of Antidiabetic Agents Used in Patients With Heart Disease
Journal of Pharmacy Practice, April 1, 2009; 22(2): 179 - 193.
[Abstract] [PDF]


Home page
Diabetes CareHome page
S. D. Bolen, E. Bricker, T. A. Samuels, H.-C. Yeh, S. S. Marinopoulos, M. McGuire, M. Abuid, and F. L. Brancati
Factors Associated With Intensification of Oral Diabetes Medications in Primary Care Provider-Patient Dyads: A Cohort Study
Diabetes Care, January 1, 2009; 32(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. S. Huang, Q. Zhang, N. Gandra, M. H. Chin, and D. O. Meltzer
The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis
Ann Intern Med, July 1, 2008; 149(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Rizza, D. Eddy, and R. Kahn
Cure, Care, and Commitment: What Can We Look Forward To?
Diabetes Care, May 1, 2008; 31(5): 1051 - 1059.
[Full Text] [PDF]


Home page
The Diabetes EducatorHome page
L. McAndrew, S. H. Schneider, E. Burns, and H. Leventhal
Does Patient Blood Glucose Monitoring Improve Diabetes Control?: A Systematic Review of the Literature
The Diabetes Educator, November 1, 2007; 33(6): 991 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Heisler, J. D. Faul, R. A. Hayward, K. M. Langa, C. Blaum, and D. Weir
Mechanisms for Racial and Ethnic Disparities in Glycemic Control in Middle-aged and Older Americans in the Health and Retirement Study
Arch Intern Med, September 24, 2007; 167(17): 1853 - 1860.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. Bolen, L. Feldman, J. Vassy, L. Wilson, H.-C. Yeh, S. Marinopoulos, C. Wiley, E. Selvin, R. Wilson, E. B. Bass, et al.
Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus
Ann Intern Med, September 18, 2007; 147(6): 386 - 399.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. A. Hayward, T. P. Hofer, and S. Vijan
Intensive Glucose Control in Elderly Adults
JAMA, May 23, 2007; 297(20): 2195 - 2195.
[Full Text] [PDF]


Home page
JAMAHome page
L. Pogach, M. Engelgau, and D. Aron
Measuring Progress Toward Achieving Hemoglobin A1c Goals in Diabetes Care: Pass/Fail or Partial Credit
JAMA, February 7, 2007; 297(5): 520 - 523.
[Full Text] [PDF]


Home page
Int J Qual Health CareHome page
D. Aron, M. Rajan, and L. M. Pogach
Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds
Int. J. Qual. Health Care, February 1, 2007; 19(1): 29 - 36.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
J. J. Gagliardino, M. d. C. Malbran, and C. Clark Jr.
Development and Implementation of Advanced Training Course for Diabetes Educators in Argentina
Diabetes Spectr, January 1, 2007; 20(1): 24 - 30.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. A. Hayward, T. P. Hofer, and S. Vijan
Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.
Ann Intern Med, October 3, 2006; 145(7): 520 - 530.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
A. J. Sinclair
Special Considerations in Older Adults With Diabetes: Meeting the Challenge
Diabetes Spectr, October 1, 2006; 19(4): 229 - 233.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. M. Pogach, M. Rajan, and D. C. Aron
Comparison of Weighted Performance Measurement and Dichotomous Thresholds for Glycemic Control in the Veterans Health Administration
Diabetes Care, February 1, 2006; 29(2): 241 - 246.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. S. Huang, M. Shook, L. Jin, M. H. Chin, and D. O. Meltzer
The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes
Diabetes Care, February 1, 2006; 29(2): 259 - 264.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association Consensus Panel
Guidelines for Computer Modeling of Diabetes and Its Complications
Diabetes Care, September 1, 2004; 27(9): 2262 - 2265.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
T. J. Hoerger, R. Harris, K. A. Hicks, K. Donahue, S. Sorensen, and M. Engelgau
Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis
Ann Intern Med, May 4, 2004; 140(9): 689 - 699.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. A. Hayward, T. P. Hofer, E. A. Kerr, and S. L. Krein
Quality Improvement Initiatives: Issues in moving from diabetes guidelines to policy
Diabetes Care, May 1, 2004; 27(suppl_2): B54 - B60.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. M. Pogach, S. A. Brietzke, C. L. Cowan Jr., P. Conlin, D. J. Walder, and C. T. Sawin
Development of Evidence-Based Clinical Practice Guidelines for Diabetes: The Department of Veterans Affairs/Department of Defense Guidelines Initiative
Diabetes Care, May 1, 2004; 27(suppl_2): B82 - B89.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Rowe, C. H. MacLean, and P. G. Shekelle
Preventing Visual Loss From Chronic Eye Disease in Primary Care: Scientific Review
JAMA, March 24, 2004; 291(12): 1487 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. M. Eddy and L. Schlessinger
Archimedes: A trial-validated model of diabetes
Diabetes Care, November 1, 2003; 26(11): 3093 - 3101.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Kahn
Dealing With Complexity in Clinical Diabetes: The value of Archimedes
Diabetes Care, November 1, 2003; 26(11): 3168 - 3171.
[Full Text] [PDF]


Home page
Clin. DiabetesHome page
C. Abraira and W. Duckworth
The Need for Glycemic Trials in Type 2 Diabetes
Clin. Diabetes, July 1, 2003; 21(3): 107 - 111.
[Abstract] [Full Text] [PDF]


Home page
Med Care Res RevHome page
M. J. V. Pugh, J. Anderson, L. M. Pogach, and D. R. Berlowitz
Differential Adoption of Pharmacotherapy Recommendations for Type 2 Diabetes by Generalists and Specialists
Med Care Res Rev, June 1, 2003; 60(2): 178 - 200.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
S. Vijan and R. A. Hayward
Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
Ann Intern Med, April 1, 2003; 138(7): 593 - 602.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. H. Saydah, M. S. Eberhardt, C. M. Loria, and F. L. Brancati
Age and the Burden of Death Attributable to Diabetes in the United States
Am. J. Epidemiol., October 15, 2002; 156(8): 714 - 719.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Raji, H. Gomes, J. O. Beard, P. MacDonald, and P. R. Conlin
A Randomized Trial Comparing Intensive and Passive Education in Patients With Diabetes Mellitus
Arch Intern Med, June 10, 2002; 162(11): 1301 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series B: Psychological Sciences and Social ScienceHome page
K. M. Langa, S. Vijan, R. A. Hayward, M. E. Chernew, C. S. Blaum, M. U. Kabeto, D. R. Weir, S. J. Katz, R. J. Willis, and A. M. Fendrick
Informal Caregiving for Diabetes and Diabetic Complications Among Elderly Americans
J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2002; 57(3): S177 - 186.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
C. E. Golin, M. DIMatteo, B. Leaks, N. Duan, and L. Gelberg
A Diabetes-Specific Measure of Patient Desire to Participate in Medical Decision Making
The Diabetes Educator, November 1, 2001; 27(6): 875 - 886.
[Abstract] [PDF]


Home page
Diabetes CareHome page
B. B. Fleming, S. Greenfield, M. M. Engelgau, L. M. Pogach, S. B. Clauser, and M. A. Parrott
The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic
Diabetes Care, October 1, 2001; 24(10): 1815 - 1820.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. J. Gagliardino and G. Etchegoyen
A Model Educational Program for People With Type 2 Diabetes: A cooperative Latin American implementation study (PEDNID-LA)
Diabetes Care, June 1, 2001; 24(6): 1001 - 1007.
[Abstract] [Full Text]


Home page
Diabetes CareHome page
W. C. Duckworth, M. McCarren, and C. Abraira
Glucose Control and Cardiovascular Complications: The VA Diabetes Trial
Diabetes Care, May 1, 2001; 24(5): 942 - 945.
[Full Text]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
G. S. Meneilly and D. Tessier
Diabetes in Elderly Adults
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 5M - 13.
[Abstract] [Full Text]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
M. H. Chin, A. W. Su, L. Jin, and M. P. Nerney
Variations in the Care of Elderly Persons With Diabetes Among Endocrinologists, General Internists, and Geriatricians
J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2000; 55(10): 601M - 606.
[Abstract] [Full Text]


Home page
The Diabetes EducatorHome page
A. R. Williamson, A. E. Hunt, J. F. Pope, and N. M. Tolman
Recommendations of Dietitians for Overcoming Barriers to Dietary Adherence in Individuals With Diabetes
The Diabetes Educator, March 1, 2000; 26(2): 272 - 279.
[Abstract] [PDF]


Home page
JAMAHome page
S. Vijan, T. P. Hofer, and R. A. Hayward
Cost-Utility Analysis of Screening Intervals for Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
JAMA, February 16, 2000; 283(7): 889 - 896.
[Abstract] [Full Text] [PDF]


Home page
American Journal of Medical QualityHome page
J. Dalewitz, N. Khan, and C. O. Hershey
Barriers to Control of Blood Glucose in Diabetes Mellitus
American Journal of Medical Quality, January 1, 2000; 15(1): 16 - 25.
[Abstract] [PDF]


Home page
JAMAHome page
M. C. Riddle, D. M. Karl, J. M. Poothullil, M. J. Lenhard, I. B. Hirsch, T. C. Evans, B. Gaster, P. V. M. Cromme, J. C. Shipp, L. Jovanovic, et al.
Insulin Treatment for Type 2 Diabetes
JAMA, May 20, 1998; 279(19): 1523 - 1526.
[Full Text] [PDF]


Home page
JAMAHome page
R. A. Hayward, W. G. Manning, S. H. Kaplan, E. H. Wagner, and S. Greenfield
Starting Insulin Therapy in Patients With Type 2 Diabetes: Effectiveness, Complications, and Resource Utilization
JAMA, November 26, 1997; 278(20): 1663 - 1669.
[Abstract] [PDF]


Home page
JWatch GeneralHome page
TIGHT CONTROL FOR TYPE 2 DIABETES?
Journal Watch (General), November 14, 1997; 1997(1114): 2 - 2.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.